Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) (Therapeutic advances in medical oncology)

The efficacy and safety of onartuzumab in patients with solid cancers: A meta-analysis of randomized trials (Indian journal of cancer)

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) (Therapeutic Advances in Medical Oncology)

Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplification (INVESTIGATIONAL NEW DRUGS)

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin / ^^영문 제목을 반드시 기재하시기 바랍니다. (cancer research and treatment)